ATE437186T1 - Anti-epcam-immunoglobuline - Google Patents

Anti-epcam-immunoglobuline

Info

Publication number
ATE437186T1
ATE437186T1 AT05707293T AT05707293T ATE437186T1 AT E437186 T1 ATE437186 T1 AT E437186T1 AT 05707293 T AT05707293 T AT 05707293T AT 05707293 T AT05707293 T AT 05707293T AT E437186 T1 ATE437186 T1 AT E437186T1
Authority
AT
Austria
Prior art keywords
immunoglobulin
human
administering
frequently
once
Prior art date
Application number
AT05707293T
Other languages
English (en)
Inventor
Malte Peters
Mathias Locher
Nadja Prang
Cornelia Quadt
Original Assignee
Micromet Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Micromet Ag filed Critical Micromet Ag
Application granted granted Critical
Publication of ATE437186T1 publication Critical patent/ATE437186T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AT05707293T 2004-02-13 2005-02-09 Anti-epcam-immunoglobuline ATE437186T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/778,915 US20050180979A1 (en) 2004-02-13 2004-02-13 Anti-EpCAM immunoglobulins
PCT/EP2005/001307 WO2005080428A2 (en) 2004-02-13 2005-02-09 Anti-epcam immunoglobulins

Publications (1)

Publication Number Publication Date
ATE437186T1 true ATE437186T1 (de) 2009-08-15

Family

ID=34838270

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05707293T ATE437186T1 (de) 2004-02-13 2005-02-09 Anti-epcam-immunoglobuline

Country Status (23)

Country Link
US (3) US20050180979A1 (de)
EP (2) EP2107071A3 (de)
JP (1) JP5220315B2 (de)
KR (1) KR101236224B1 (de)
CN (1) CN1976951B (de)
AT (1) ATE437186T1 (de)
AU (1) AU2005215874B2 (de)
BR (1) BRPI0507660A (de)
CA (1) CA2555694C (de)
DE (1) DE602005015544D1 (de)
DK (1) DK1713830T3 (de)
EA (1) EA011951B1 (de)
ES (1) ES2328159T3 (de)
IL (1) IL177069A (de)
MX (1) MXPA06008942A (de)
NO (1) NO339364B1 (de)
NZ (1) NZ549125A (de)
PL (1) PL1713830T3 (de)
PT (1) PT1713830E (de)
SI (1) SI1713830T1 (de)
UA (1) UA87128C2 (de)
WO (1) WO2005080428A2 (de)
ZA (1) ZA200606083B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004068110A2 (en) 2003-01-24 2004-08-12 University Of Utah Methods of predicting mortality risk by determining telomere length
WO2007008943A2 (en) 2005-07-08 2007-01-18 Xencor, Inc. Optimized anti-ep-cam antibodies
CA2638040A1 (en) * 2006-02-09 2007-08-16 Micromet Ag Treatment of metastatic breast cancer
EP1865001A1 (de) * 2006-06-08 2007-12-12 Gsf-Forschungszentrum Für Umwelt Und Gesundheit, Gmbh Spezifische Proteaseinhibitoren und ihre Verwendung in der Krebstherapie
ATE509956T1 (de) * 2006-06-08 2011-06-15 Helmholtz Zentrum Muenchen Spezifische proteaseinhibitoren und ihre verwendung in der krebstherapie
EP2142570B1 (de) * 2007-04-04 2011-06-15 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Antikörper gegen epcam und anwendungen davon
US9689028B2 (en) 2008-12-22 2017-06-27 University Of Utah Foundation Monochrome multiplex quantitative PCR
AU2010295172B2 (en) * 2009-09-21 2016-08-04 Ranju Ralhan Methods and compositions for the diagnosis and treatment of thyroid cancer
TWI485161B (zh) * 2012-03-02 2015-05-21 中央研究院 抗上皮細胞黏著分子（ＥｐＣＡＭ）抗體及其使用方法
CN103387989B (zh) * 2012-09-24 2016-05-18 厦门大学 上皮细胞粘附分子的核酸适体EpCAM D及其制备方法
EP2999800B1 (de) 2013-05-22 2019-09-25 Telomere Diagnostics Inc. Messung der menge kurzer telomere
CN103275226B (zh) * 2013-06-09 2017-08-29 中国科学技术大学 特异性抗人上皮细胞粘附分子（EpCAM）的单克隆抗体的制备、鉴定及应用
ES3012974T3 (en) * 2014-01-08 2025-04-10 Univ Leland Stanford Junior Targeted therapy for lung cancer
US9944978B2 (en) 2014-12-30 2018-04-17 Telomere Diagnostics, Inc. Multiplex quantitative PCR
ES2873846T5 (en) * 2015-11-19 2025-06-23 Revitope Ltd Functional antibody fragment complementation for a two-components system for redirected killing of unwanted cells
US20190262397A1 (en) 2016-07-26 2019-08-29 Tessa Therapeutics Pte. Ltd. Chimeric antigen receptor
WO2020018964A1 (en) 2018-07-20 2020-01-23 Fred Hutchinson Cancer Research Center Compositions and methods for controlled expression of antigen-specific receptors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5853697A (en) * 1995-10-25 1998-12-29 The United States Of America, As Represented By The Department Of Health & Human Services Methods of treating established colitis using antibodies against IL-12
BRPI9809391B8 (pt) * 1997-04-14 2021-05-25 Amgen Res Munich Gmbh processo para a produção de um receptor de antígeno anti-humano, anticorpo humano e composição farmacêutica
US6855544B1 (en) * 1999-04-15 2005-02-15 Crucell Holland B.V. Recombinant protein production in a human cell
US7605238B2 (en) * 1999-08-24 2009-10-20 Medarex, Inc. Human CTLA-4 antibodies and their uses
PT1383785E (pt) * 2001-05-03 2011-06-28 Merck Patent Gmbh Anticorpo recombinante específico de tumores e utilização deste
US20030175268A1 (en) * 2002-01-11 2003-09-18 Saint-Remy Jean-Marie R. Method and pharmaceutical composition for preventing and/or treating systemic inflammatory response syndrome
WO2003099205A2 (en) * 2002-05-20 2003-12-04 Abgenix, Inc. Treatment of renal carcinoma using antibodies against the egfr

Also Published As

Publication number Publication date
CN1976951A (zh) 2007-06-06
WO2005080428A3 (en) 2005-11-10
JP5220315B2 (ja) 2013-06-26
ES2328159T3 (es) 2009-11-10
EA011951B1 (ru) 2009-06-30
EP2107071A3 (de) 2009-12-30
KR20070009988A (ko) 2007-01-19
EP1713830B1 (de) 2009-07-22
EA200601386A1 (ru) 2007-06-29
HK1096103A1 (en) 2007-05-25
UA87128C2 (ru) 2009-06-25
NO339364B1 (no) 2016-12-05
SI1713830T1 (sl) 2009-10-31
EP1713830A2 (de) 2006-10-25
KR101236224B1 (ko) 2013-02-22
BRPI0507660A (pt) 2007-07-17
CA2555694A1 (en) 2005-09-01
AU2005215874B2 (en) 2011-01-27
WO2005080428A2 (en) 2005-09-01
CA2555694C (en) 2013-04-16
NO20064136L (no) 2006-11-07
DK1713830T3 (da) 2009-10-12
AU2005215874A1 (en) 2005-09-01
PT1713830E (pt) 2009-10-19
US20120294873A1 (en) 2012-11-22
ZA200606083B (en) 2007-10-31
PL1713830T3 (pl) 2010-01-29
JP2008500277A (ja) 2008-01-10
IL177069A0 (en) 2006-12-10
CN1976951B (zh) 2012-03-14
EP2107071A2 (de) 2009-10-07
US20070274982A1 (en) 2007-11-29
NZ549125A (en) 2008-09-26
IL177069A (en) 2010-11-30
MXPA06008942A (es) 2007-01-26
US20050180979A1 (en) 2005-08-18
DE602005015544D1 (de) 2009-09-03

Similar Documents

Publication Publication Date Title
DK1713830T3 (da) Anti-epcam-immunglobuliner
DK1734995T3 (da) Monoklonale antistoffer og hepatocyytvækstfaktor
MXPA06003788A (es) Anticuerpos completamente humanos contra 4-1bb humano (cd137).
EA200970262A1 (ru) Композиции и способы, относящиеся к антителам к глюкагоновым рецепторам
CY1110033T1 (el) Τεχνητα ανθρωπινα θεραπευτικα αντισωματα εναντια σε ισομορφες cd45
ATE455127T1 (de) Humane anti-humane cd3-bindungsmoleküle
ATE470676T1 (de) Anti-vegf-2 antikörper
CY1116776T1 (el) Αντισωματα ειδικα για τα διαλυτα πρωτοϊνιδια των πεπτιδιων β-αμυλοειδους και χρησεις αυτων
WO2003076585A3 (en) Controlled modulation of amino acid side chain length of peptide antigens
DK1534335T3 (da) FcgammaRIIB-specifikke antistoffer og fremgangsmåder til anvendelse deraf
DK1401498T3 (da) Anti-NGF-antistoffer til behandlingen af forskellige sygdomme
ATE517920T1 (de) Humanisierte antikörper gegen interferon-alpha- rezeptor-1 (ifnar-1)
DE60306505D1 (de) Verfahren zur behandlung von brustdrüsenerkrankungen
TW200517124A (en) Fully human antibodies against human 4-1BB
ATE364396T1 (de) Behandlung von pilzinfektion mit polyenen oder beta glucan synthese hemmern kombiniert mit anti- hsp antikörpern
DK1684770T3 (da) Oligo-beta-(1, 3) -glucan og monoklonale antistoffer mod kræft
WO2003097082A3 (en) Treatment of crohn's disease or psoriasis using anti-inteferon gamma antibodies
SG156658A1 (en) Treatment of diseases
CY1116887T1 (el) Anti-cd19 αντισωματα και χρησεις στην ογκολογια
CY1114835T1 (el) Πληρη ανθρωπινα αντισωματα εναντι ανθρωπινου 4-1ββ (cd137)

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1713830

Country of ref document: EP